Tikun Olam Cannbit Pharmaceuticals Ltd (TKUN) - Cash Flow Conversion Efficiency

Latest as of June 2023: -0.082x

Based on the latest financial reports, Tikun Olam Cannbit Pharmaceuticals Ltd (TKUN) has a cash flow conversion efficiency ratio of -0.082x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-4.35 Million ≈ $-11.66K USD) by net assets (ILA53.22 Million ≈ $142.69K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Tikun Olam Cannbit Pharmaceuticals Ltd stock valuation for the company's overall valuation and market capitalisation.

Tikun Olam Cannbit Pharmaceuticals Ltd - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Tikun Olam Cannbit Pharmaceuticals Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Tikun Olam Cannbit Pharmaceuticals Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tikun Olam Cannbit Pharmaceuticals Ltd ranked by their cash flow conversion efficiency. See Tikun Olam Cannbit Pharmaceuticals Ltd debt service capacity to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
eHealth Inc NASDAQ:EHTH	0.057x
ABVC Biopharma Inc NASDAQ:ABVC	-0.020x
Ascent Solar Technologies, Inc. NASDAQ:ASTI	-0.065x
Bonava AB (publ) ST:BONAV-A	-0.022x
Korea Eng Cons KO:023350	-0.096x
Pico (Thailand) Public Company Limited BK:PICO	-0.070x
Megachem (Thailand) Public Company Limited BK:MGT	0.034x
Aquaron Acquisition Corp. Common Stock NASDAQ:AQU	-0.032x

Annual Cash Flow Conversion Efficiency for Tikun Olam Cannbit Pharmaceuticals Ltd (2017–2024)

The table below shows the annual cash flow conversion efficiency of Tikun Olam Cannbit Pharmaceuticals Ltd from 2017 to 2024. View Tikun Olam Cannbit Pharmaceuticals Ltd (TKUN) share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	ILA-5.35 Million ≈ $-14.34K	ILA-3.77 Million ≈ $-10.11K	0.705x	+870.69%
2023-12-31	ILA33.04 Million ≈ $88.59K	ILA-3.02 Million ≈ $-8.11K	-0.092x	+41.26%
2022-12-31	ILA116.92 Million ≈ $313.46K	ILA-18.22 Million ≈ $-48.84K	-0.156x	+3.30%
2021-12-31	ILA143.82 Million ≈ $385.59K	ILA-23.17 Million ≈ $-62.13K	-0.161x	+10.07%
2020-12-31	ILA136.06 Million ≈ $364.77K	ILA-24.38 Million ≈ $-65.36K	-0.179x	-433.18%
2019-12-31	ILA99.87 Million ≈ $267.75K	ILA-3.36 Million ≈ $-9.00K	-0.034x	+99.79%
2018-12-31	ILA108.00K ≈ $289.54	ILA-1.76 Million ≈ $-4.71K	-16.278x	-7635.02%
2017-12-31	ILA-492.00K ≈ $-1.32K	ILA-106.29K ≈ $-284.95	0.216x	--

About Tikun Olam Cannbit Pharmaceuticals Ltd

TA:TKUN Israel Drug Manufacturers - Specialty & Generic

Market Cap

$15.56 Billion

ILA5.80 Trillion ILA

Market Cap Rank

#24070 Global

#334 in Israel

Share Price

ILA68300.00

Change (1 day)

-23.77%

52-Week Range

ILA17.03 - ILA89600.00

All Time High

ILA89600.00